$28.45
0.020.07%
In chiusura: Nov 13, 4:00 PM EST
$28.20
-0.23-0.81%
Pre-mercato: 8:11 AM EST
The average analyst price target for Parabilis Medicines is $40.80, 44.7% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $39 to $45. The latest change came on Nov 9, 2026, when Canaccord Genuity initiated coverage of Parabilis Medicines with a Buy rating and a $39 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
